Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase.
Isobe
M
M
First Department of Internal Medicine, Shinshu University, Matsumoto, Japan.
Suzuki
J
J
Morishita
R
R
Kaneda
Y
Y
Sawa
Y
Y
Matsuda
H
H
Ogihara
T
T
Horie
S
S
Okubo
Y
Y
Amano
J
J
D000818:Animals; D042846:CDC2-CDC28 Kinases; D003324:Coronary Artery Disease / Q000473:pathology / Q000517:prevention & control*; D003331:Coronary Vessels / Q000276:immunology* / Q000473:pathology; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases / Q000096:biosynthesis* / Q000235:genetics; D016232:Endothelins / Q000037:antagonists & inhibitors / Q000096:biosynthesis*; D015316:Genetic Therapy / Q000379:methods; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D011183:Postoperative Complications; D017346:Protein Serine-Threonine Kinases / Q000096:biosynthesis* / Q000235:genetics; D016559:Tacrolimus / Q000627:therapeutic use; D014162:Transfection
D016232:Endothelins; D007166:Immunosuppressive Agents; D016376:Oligonucleotides, Antisense; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; C495894:CDK2 protein, human; C495893:Cdk2 protein, mouse; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases; D016559:Tacrolimus